Business / Finance

RSS

AbleNet announces acquisition of TeleConcepts

AbleNet announced today the acquisition of TeleConcepts, a company with over 25 years experience and success with direct telephone outreach. Their primary customer base includes professionals who serve the hard of hearing market. AbleNet sees this as an important part of meeting the full needs of individuals with disabilities.

1 Jun 2011

Radiant to expand consumer products testing capabilities

Radiant Research, Inc. today announced that it is expanding its consumer products testing capabilities through creation of a new division of Radiant Research devoted to consumer trial conduct.

31 May 2011

Ashland agrees to acquire ISP

Ashland Inc. and International Specialty Products Inc. today announced that Ashland has agreed to acquire privately owned ISP, a global specialty chemical manufacturer of innovative functional ingredients and technologies.

31 May 2011

BioAlliance's appeals in SpePharm litigation rejected

SpePharm Holding B.V. announces that the appeals lodged by BioAlliance Pharma S.A. - a French company listed on Paris Euronext - before the Paris Court of Appeals have been rejected.

31 May 2011

EpiCept completes $10.6 million 11.5% senior secured term loan facility with MidCap Financial

EpiCept Corporation today announced that it has completed a $10.6 million 11.5% senior secured term loan facility with MidCap Financial LLC.

31 May 2011

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary multiplexing technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the second quarter ended March 31, 2011.

30 May 2011

NovaShunt launches new corporate identity and product branding

NovaShunt AG has launched a new corporate identity and product branding to support its goal of leadership in the area of fluid management within the body. The company will now operate as Sequana Medical AG it prepares for the upcoming launch of the ALFApump System in Europe.

30 May 2011

Lilly disappointed with Court's decision to grant Amylin's request for temporary restraining order

Eli Lilly and Company today commented on a ruling issued by the U.S. District Court for the Southern District of California granting a request by Amylin Pharmaceuticals for a temporary restraining order (TRO) related to litigation involving the two companies' diabetes collaboration agreement.

27 May 2011

Brazilian Court denies claims for indemnification for damages attributed to smoking cigarettes

The judge of the 19th Civil Court of Sao Paulo denied the claims for indemnification brought by the Association for the Defence of the Health of Smokers (ADESF) in a class action suit filed against cigarette manufacturers Souza Cruz and Philip Morris Brasil that, according to the plaintiff, was evaluated at more than R$ 30 billion (US$ 18.4 billion).

27 May 2011

Express Scripts enters into two accelerated share repurchase programs

Express Scripts, Inc. announced that it has entered into two accelerated share repurchase, or ASR, transactions with Morgan Stanley to purchase shares of Express Scripts' common stock for an aggregate purchase price of $1,750 million. Under the terms of the transactions, the Company will initially receive approximately 29.4 million shares of its stock.

27 May 2011

California's largest non-profit insurer releases details of executive pay

For the first time, California's largest nonprofit health insurer has released the salaries of its 10 highest-paid executives in response to a new state law intended to keep health care insurance costs under control.

27 May 2011

International Dairy Federation releases new publication on Integrated Supply Chain Management

Recent food crises have highlighted the sharp need for the prevention of possible adulteration of suppliers' milk through the implementation of integrated chain management principles. As part of the dairy sector's commitment to food safety, the International Dairy Federation (IDF) has just released a new publication on "Integrated Supply Chain Management".

27 May 2011

Sanofi-Aventis, Medtronic under scrutiny in press reports

ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.

27 May 2011

Mylan plans to change name of Matrix Laboratories

Mylan Inc. today announced that it plans to rebrand its Hyderabad, India-based subsidiary Matrix Laboratories Limited as Mylan.

27 May 2011

Wolters Kluwer Health acquires Lexi-Comp

Wolters Kluwer Health today announced that it has completed the acquisition of Lexi-Comp, Inc., a leading provider of drug information and clinical content for pharmacists, clinicians and hospitals internationally.

27 May 2011

Pro-Pharmaceuticals announces name change to Galectin Therapeutics

Pro-Pharmaceuticals, Inc. today announced that it has changed its name to Galectin Therapeutics Inc. to more accurately reflect the Company's core expertise in galectin science and its leading platform for the creation of galectin inhibitors to treat serious diseases including fibrosis and cancer.

27 May 2011

Patterson Companies fourth quarter consolidated sales increase 9% to $883,819,000

Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.

26 May 2011

HP, Healthways sign 10-year applications and technology services outsourcing agreement

HP Enterprise Services and Healthways, Inc. today announced the signing of a 10-year, $380 million applications and technology services outsourcing agreement to support growth and expand value to Healthways' customers.

26 May 2011

Quality Systems fiscal 2011 fourth quarter net revenues increase 24% to $97.1 million

Quality Systems, Inc. announced today results for its fiscal 2011 fourth quarter and year ended March 31, 2011.

26 May 2011

Neoprobe, Devicor sign gamma detection device asset purchase agreement

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.

26 May 2011